Dosage form | Drug name | Case (number for analysis) | Median of time-to-onset (day) | Lower quartile of time-to-onset (day) | Upper quartile of time-to-onset (day) | Scale parameter: α | Shape parameter: β | |||
---|---|---|---|---|---|---|---|---|---|---|
α | (95 % CI) | β | (95 % CI) | |||||||
Intravenous | Pamidronate (30 − 45 mg) | 44 | (35) | 844 | 658 | 1,199 | 775.6 | (641.8 − 928.9) | 1.98 | (1.49 − 2.53) |
Pamidronate (90 mg) | 66 | (48) | 783 | 532 | 1,041 | 889.5 | (706.1 − 1112.6) | 1.35 | (1.09 − 1.63) | |
Zoredronate (4 mg) | 494 | (355) | 488 | 290 | 811 | 634.1 | (587.7 − 683.4) | 1.46 | (1.34 − 1.59) | |
Oral | Arendronate (5 mg) | 155 | (72) | 1,263 | 757 | 1,951 | 1450.5 | (1258.1 − 1664.5) | 1.77 | (1.46 − 2.12) |
Arendronate (35 mg) | 202 | (102) | 680 | 309 | 1,106 | 804.9 | (663.0 − 972.3) | 1.08 | (0.91 − 1.25) | |
Risedronate (2.5 mg) | 73 | (39) | 1,081 | 495 | 1,706 | 1288.6 | (1008.4 − 1634.3) | 1.41 | (1.06 − 1.82) | |
Risedronate (17.5 mg) | 35 | (14) | 112 | 33 | 407 | 295.0 | (129.5 − 636.9) | 0.82 | (0.96 − 1.23) |